Zhengjun Zhou

Zhongshan, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Use of a Pathomics Signature to Predict the Prognosis of Hepatocellular Carcinoma with Cirrhosis: A Multicentre Retrospective Study.

Use of a Pathomics Signature to Predict the Prognosis of Hepatocellular Carcinoma with Cirrhosis: A Multicentre Retrospective Study.

Journal: Cancers

Published: August 13, 2025

Association of IDH1 mutations with survival and recurrence in resected intrahepatic cholangiocarcinoma received or not received adjuvant chemotherapy.

Association of IDH1 mutations with survival and recurrence in resected intrahepatic cholangiocarcinoma received or not received adjuvant chemotherapy.

Journal: The oncologist

Published: July 31, 2025

Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice.

Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice.

Journal: Frontiers in pharmacology

Published: March 04, 2025

GALNT6 drives lenvatinib resistance in hepatocellular carcinoma through autophagy and cancer-associated fibroblast activation.

GALNT6 drives lenvatinib resistance in hepatocellular carcinoma through autophagy and cancer-associated fibroblast activation.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 19, 2024

LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinoma.

LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: May 17, 2024

A novel protein encoded by circFOXP1 enhances ferroptosis and inhibits tumor recurrence in intrahepatic cholangiocarcinoma.

A novel protein encoded by circFOXP1 enhances ferroptosis and inhibits tumor recurrence in intrahepatic cholangiocarcinoma.

Journal: Cancer letters

Published: March 17, 2024

Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma.

Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma.

Journal: Cancer letters

Published: November 01, 2023

rAAV capsid mutants eliminate leaky expression from DNA donor template for homologous recombination.

rAAV capsid mutants eliminate leaky expression from DNA donor template for homologous recombination.

Journal: Nucleic acids research

Published: May 26, 2023

Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression.

Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression.

Journal: Hepatology (Baltimore, Md.)

Published: March 03, 2021

Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3.

Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3.

Journal: Journal for immunotherapy of cancer

Published: February 10, 2021

Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma.

Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: February 01, 2021

Characterization of immune infiltration in sarcomatoid hepatocellular carcinoma.

Characterization of immune infiltration in sarcomatoid hepatocellular carcinoma.

Journal: Aging

Published: November 03, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026